subscribeSubscribe
Zealand says US FDA turns down drug for low blood sugar in infants

Zealand says US FDA turns down drug for low blood sugar in infants
REUTERS
21 Dec 2023
Share Share
Zealand announces designation of priority review by the US FDA for dasiglucagon

Zealand announces designation of priority review by the US FDA for dasiglucagon
GLOBENEWSWIRE
30 Aug 2023
Share Share
Zealand Pharma submits New Drug Application to US FDA for dasiglucagon

Zealand Pharma submits New Drug Application to US FDA for dasiglucagon
GLOBENEWSWIRE
30 Jun 2023
Share Share
Zealand Pharma Submits MAA for Dasiglucagon

Zealand Pharma Submits MAA for Dasiglucagon
GLOBENEWSWIRE
26 Jun 2023
Share Share
Zealand Pharma Presents Data from Phase 3 Trial of Dasiglucagon

Zealand Pharma Presents Data from Phase 3 Trial of Dasiglucagon
GLOBENEWSWIRE
20 Sep 2022
Share Share
Zealand Presents Data from Ph3 Trial Dasiglucagon Congenital Hyperinsulinism

Zealand Presents Data from Ph3 Trial Dasiglucagon Congenital Hyperinsulinism
GLOBENEWSWIRE
19 Sep 2022
Share Share
Zealand Pharma Announces License & Agreement with Novo Nordisk for ZEGALOGUE

Zealand Pharma Announces License & Agreement with Novo Nordisk for ZEGALOGUE
GLOBENEWSWIRE
08 Sep 2022
Share Share
Zealand Announces Global License and Development Agreement with Novo Nordisk

Zealand Announces Global License and Development Agreement with Novo Nordisk
GLOBENEWSWIRE
07 Sep 2022
Share Share
Zealand Pharma reports positive PIII results against congenital hyperinsulinism

Zealand Pharma reports positive PIII results against congenital hyperinsulinism
Daniel Pederson MEDWATCH
19 May 2022
Share Share
Advancement of Clinical Pipeline; Key Data for Glepaglutide and Dasiglucagon

Advancement of Clinical Pipeline; Key Data for Glepaglutide and Dasiglucagon
GLOBENEWSWIRE
11 Mar 2022
Share Share